Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Non Operating Income (2020 - 2025)

Biofrontera has reported Non Operating Income over the past 6 years, most recently at $632000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $632000.0 for Q4 2025, up 192.8% from a year ago — trailing twelve months through Dec 2025 was $741000.0 (up 161.7% YoY), and the annual figure for FY2025 was $388000.0, up 173.62%.
  • Non Operating Income for Q4 2025 was $632000.0 at Biofrontera, up from $30000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for BFRIW hit a ceiling of $8.7 million in Q1 2022 and a floor of -$15.1 million in Q4 2022.
  • Median Non Operating Income over the past 5 years was $500.0 (2021), compared with a mean of -$605350.0.
  • Biggest five-year swings in Non Operating Income: soared 174120.0% in 2022 and later crashed 7722.73% in 2023.
  • Biofrontera's Non Operating Income stood at -$12.6 million in 2021, then dropped by 19.68% to -$15.1 million in 2022, then surged by 131.45% to $4.8 million in 2023, then tumbled by 114.34% to -$681000.0 in 2024, then surged by 192.8% to $632000.0 in 2025.
  • The last three reported values for Non Operating Income were $632000.0 (Q4 2025), $30000.0 (Q3 2025), and -$264000.0 (Q2 2025) per Business Quant data.